Revolutionizing Health Care

I grew up in a family full of physicians.

Large, multi-generational gatherings of aunts, uncles, and cousins usually devolved into cliquey, closed-conversation huddles with the division defined along simple lines: those who worked in medicine and those who probably drank a bit too much, weren’t smart enough, were too lazy, or were too “artistic” and, as a result, did other things.

I obviously fell into the “other” category, but the constant exposure to this community rubbed off on me just enough for me to have cultivated a great respect for the profession.

Doctors — good ones, anyway — are scientists and artists at the same time. They do a job that requires not just skill but also passion to be even passable.

Being from the former Soviet Union, where both of my parents received their initial medical training, the concept of medicine and greed doesn’t ring true to me the way it does for most Americans.

None of the older generation — those who first started to practice medicine in the motherland — ever did it for the money. Ever.

Back in the day of the hammer and sickle, doctors were not paid any more than any other skilled laborer, and their skills and talents afforded them no privileges above that of their neighbors.

It took my dad four years of waiting just to get his first car: a Moskvitch — one of about three models that every member of the non-ruling class drove.

The one benefit I admit this system had was that nobody was ever embarrassed on the road.

Because unless you were a high-ranking member of the party, everyone was the same: miserable.

Flash-Forward

After three-plus decades of living in the U.S., however, I’ve seen my share of the other side of the coin.

In the U.S., doctors are named alongside lawyers and bankers as professions carrying the highest potential for monetary reward.

It’s largely a misconception, of course, as I’ve yet to meet a single doctor who makes as much as a Wall Street bigwig. But perception is 90% of reality, so there it is.

What makes it worse for the medical industry is that unlike the other examples of top-earning careers to pursue, this one deals with health, disease, suffering, longevity, and quality of life.

So to profit from the healing of others is seen as profiting from suffering — no matter how much work, stress, and talent goes into the services rendered.

Add to that the growing frustration with health insurance coverage in this country, as well as the now-prevalent practice of “defensive medicine” (ordering too many tests too often for too broad a list of diseases in order to preempt future potential malpractice litigation), and costs to the individual skyrocket.

The Rise in Cost is Always Passed on to You

I remember getting a physical done around my 30th birthday. What I thought was going to be a half-hour with the PA and then a few words with the doctor turned into a battery of tests — some of which I was at least 15 years too young to be receiving — and a referral for even more tests, scans, and evaluations by specialists I knew I did not need to see.

I followed the doctor’s instructions, got everything done, and got the results I wanted and expected… Then, when it came time to apply for new medical insurance a year or so later, guess what?

My premiums were that of a 60-year-old chronic smoker just because of all the tests I had done and all the doctor’s visits I made.

And I was a healthy 30-year-old. I could drive myself to these appointments and deal with the stress with no help. What would they have done with a sick senior citizen?

What was free and miserable in Russia is now unaffordable and inefficient here in the U.S.

And despite what people who don’t like the fact that their orthopedic surgeon drives a Mercedes might believe, the vast majority of profits derived from the health care industry goes into the pockets of insurance companies, not individual physicians.

It’s a bloated system that has proven too hard to improve or even reform through legislation or organic market evolution.

Any attempts at regulation just create more red tape, more partisan warfare in Washington, D.C., and, generally speaking, at least one major group of citizens feeling either shortchanged or disenfranchised.

The addition of more layers of red tape, higher rates of litigation, and higher profit margins for the insurers has led to decades of disproportionate health care cost increases.

They’ve outstripped the rest of the economy five-fold, expanding to the point where millions are simply priced out of this life-or-death market because too much of their income would be swallowed by financial burden.

This leads to a sicker population… which leads to higher health insurance premiums for everybody.

And so on and so on.

So what needs to be done?

Break It Down… From the First Doctor’s Visit

Well, instead of overhauling a system that’s flawed at the base, the first step should be something that changes the goal of the medical industry altogether.

Efficiency over redundancy; cost effectiveness over defensive medicine and overhead inflated by the fear of litigation.

Up until recently, those would have been nothing more than vague and unrealistic calls to action, with no true method to actually make it work.

But what if there was a technology… an actual device… that could knock over the first domino in rebuilding the health care industry from the bottom up?

What if there was a device that could perform the basic tasks a doctor’s office performs to screen for some very basic, highly prevalent diseases — but do so at a fraction of the cost?

What if it could give accurate, reliable results in as little as 10 minutes on whether you have HIV, cancer, hepatitis, or a long list of other communicable, dangerous diseases?

What if the individual test cost only several dollars to administer but provided actionable results that would have otherwise required thousands of dollars in biopsies, blood work, and additional tissue sampling, not to mention days or weeks of waiting for the news?

21st Century Medicine: Leaner, Smarter, Faster, Better

Today, there is such a device, and it’s already changing the way doctors’ offices execute their first interactions with new patients.

It has already proven to be remarkably effective in cutting costs, wait times, and untold stress on the parts of patients and patient families.

During clinical trials, this device created a greater than 40% reduction in the number of biopsies required for men showing early signs of prostate cancer.

It proved effective in spotting 42 out of 43 types of high-grade cancer.

It radically reduced the false-alarm rate over standard (and far more expensive) cancer screens.

And it did this all at pennies on the dollar compared to what our current system has established as the benchmark.

If this device sounds like a game changer, that’s because it’s already becoming one.

In the coming years, hundreds of millions of these tests will be administered, saving many billions in costs.

And it comes from a company that’s making its name as an innovative biotech brand, headed up by perhaps the most successful biotech magnate in modern history.

There is a lot more to this story, with a lot more surprises and information on how this biotech company is becoming the first of a new vanguard to embrace efficient health care practices.

Check out the video here absolutely free of charge.

Fortune favors the bold,

Alex Koyfman

Check us out on YouTube!

His flagship service, Microcap Insider, provides market-beating insights into some of the fastest moving, highest profit-potential companies available for public trading on the U.S. and Canadian exchanges. With more than 5 years of track record to back it up, Microcap Insider is the choice for the growth-minded investor. Alex contributes his thoughts and insights regularly to Energy and Capital. To learn more about Alex, click here.